Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycinebetaine SCHEMBL4263705 | 0.83 | TSHR (0.37) | TSHRTDP1NPSR1 | |
| SCHEMBL16264827 | 0.82 | TSHR (0.47) | TSHRTDP1CYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL170670 | 0.80 | TSHR (0.46) | TSHRTDP1CYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL628320 | 0.79 | TSHR (0.55) | TSHRTDP1CYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL9683567 | 0.79 | TSHR (0.50) | TSHRTDP1CYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL7919563 | 0.79 | TSHR (0.46) | TSHRTDP1CYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL11053476 | 0.79 | TSHR (0.42) | TSHRTDP1CYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL23254252 | 0.78 | TDP1 (0.49) | TSHRTDP1CYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL4594552 | 0.77 | TSHR (0.41) | TSHRTDP1CYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL11348362 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 372 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230055665-A1 | DELIVERY CARRIER INTO CELL | ITO, KABUSIKIKAISYA (JP) | 2023-02-23 | — | — | US | claimed |
| US-20200246449-A1 | INTRAVENOUS IMMUNOGLOBULIN COMPOSITIONS SPECIFIC FOR RESPIRATORY SYNCYTIAL VIRUS AND METHODS OF MAKING AND USING THE SAME | NANOBIO CORPORATION (US) | 2020-08-06 | — | — | US | claimed |
| WO-2018204669-A1 | INTRAVENOUS IMMUNOGLOBULIN COMPOSITIONS SPECIFIC FOR RESPIRATORY SYNCYTIAL VIRUS AND METHODS OF MAKING AND USING THE SAME | NANOBIO CORPORATION (US) | 2018-11-08 | — | — | WO | claimed |
| EP-2729169-A1 | HUMAN RESPIRATORY SYNCYTIAL VIRUS VACCINE | Nanobio Corporation (US) | 2014-05-14 | — | — | EP | claimed |
| US-20130011443-A1 | HUMAN RESPIRATORY SYNCYTIAL VIRUS VACCINE | NANOBIO CORPORATION | 2013-01-10 | — | — | US | claimed |
| WO-2013006797-A1 | HUMAN RESPIRATORY SYNCYTIAL VIRUS VACCINE | NANOBIO CORPORATION (US) | 2013-01-10 | — | — | WO | claimed |
| US-20120276182-A1 | METHODS OF TREATING FUNGAL, YEAST AND MOLD INFECTIONS | NANOBIO CORPORATION | 2012-11-01 | — | — | US | claimed |
| US-20120219602-A1 | METHODS FOR TREATING HERPES VIRUS INFECTIONS | NANOBIO CORPORATION | 2012-08-30 | — | — | US | claimed |
| US-8211879-B2 | Cationic steroid antimicrobial compositions and methods of use | BRIGHAM YOUNG UNIVERSITY (US) | 2012-07-03 | — | — | US | claimed |
| US-20120064136-A1 | ANTI-AGING AND WRINKLE TREATMENT METHODS USING NANOEMULSION COMPOSITIONS | NANOBIO CORPORATION | 2012-03-15 | — | — | US | claimed |
| EP-1203012-A2 | REFOLDING OF MEMBRANE PROTEINS USING TWO DIFFERENT DETERGENTS | M-Phasys GmbH (DE) | 2002-05-08 | — | — | EP | claimed |
| WO-2001014407-A2 | REFOLDING OF MEMBRANE PROTEINS, USING TWO DIFFERENT DETERGENTS | M-PHASYS GMBH (DE) | 2001-03-01 | — | — | WO | claimed |
| EP-1072312-A2 | Acid resistant catalyst sheet and process for producing same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-01-31 | — | — | EP | claimed |
| EP-1072311-A2 | Heat resistant catalyst sheet and process for producing same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-01-31 | — | — | EP | claimed |
| US-5900386-A | GROUP IB OR 8 METALS ON SUPPORT | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1999-05-04 | — | — | US | claimed |
| CN-1211193-A | Contraceptive release systems with antibacterial and/or antiviral effect | SCHERING AG (DE) | 1999-03-17 | — | — | CN | claimed |
| EP-0576425-A1 | METHOD FOR INACTIVATING ENVELOPED VIRUSES AND SPERM | E.B. MICHAELS RESEARCH ASSOCIATES, INC. (US) | 1994-01-05 | — | — | EP | claimed |
| WO-1992016201-A1 | METHOD FOR INACTIVATING ENVELOPED VIRUSES AND SPERM | E.B. MICHAELS RESEARCH ASSOCIATES, INC. (US) | 1992-10-01 | — | — | WO | claimed |
| US-4252656-A | AEROSOL CONTAINING CATIONIC POLYMER, SOFTENING AND FOAMING AGENTS, STABILIZER, HUMECTANT, WATER, AND PROPELLANT; LAUNDRY DRIERS | COLGATE-PALMOLIVE COMPANY (US) | 1981-02-24 | — | — | US | claimed |
| US-4041205-A | SURFACTANTS AND A REINFORCEMENT SELECTED FROM CELLULOSE, PROTEIN, AND NYLON | COLGATE-PALMOLIVE COMPANY (US) | 1977-08-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230055665-A1 | DELIVERY CARRIER INTO CELL | CTSA, ATG4A, ATG7 | TSHR 4448/4885TDP1 3619/4885CYP3A4 959/4885 |
| US-20120219602-A1 | METHODS FOR TREATING HERPES VIRUS INFECTIONS | STING1, IFNG, NGF | TSHR 4826/4885TDP1 1192/4885CYP3A4 4587/4885 |
| US-20120276182-A1 | METHODS OF TREATING FUNGAL, YEAST AND MOLD INFECTIONS | DPM1, ERG28, CYP51A1 | TSHR 4862/4885TDP1 2530/4885CYP3A4 1201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.